Literature DB >> 945499

Significance of creatine phosphokinase isoenzymes in Duchenne dystrophy.

L M Silverman, J R Mendell, Z Sahenk, M B Fontana.   

Abstract

Study of creatine phosphokinase (CPK) isoenzymes using a quantitative column chromatographic technique showed that there was a significant difference in serum MB isoenzyme activity between patients with Duchenne muscular dystrophy (42 mU per milliter) and those with other kinds of neuromuscular diseases (8 mU per milliter). In the Duchenne patients, the serum MB isoenzyme activity did not correlate with clinical cardiac disease. Furthermore, skeletal muscle damage produced in the rat by aortic ligation and 5-hydroxytryptamine resulted in significant elevations of plasma MB isoenzyme activty. These studies suggest that the serum MB isoenzyme activity in the Duchenne muscular dystrophy patients is probably arising from skeletal, not cardiac muscle and may reflect a distinct pathogenesis from other kinds of neuromuscular disorders.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 945499     DOI: 10.1212/wnl.26.6.561

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

2.  Skeletal muscle injury and repair in marathon runners after competition.

Authors:  M J Warhol; A J Siegel; W J Evans; L M Silverman
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

3.  Increased MB-creatine kinase isoenzymes in an alcoholic population.

Authors:  R J Siegel; M Kligerman; L J Haywood; W E Shell
Journal:  J Natl Med Assoc       Date:  1985-06       Impact factor: 1.798

4.  [Studies of activity kinetic of isoenzyme CK-MB in serum after myocardial infarction (author's transl)].

Authors:  D Neumeier; W Prellwitz; P Sandel; M Knedel
Journal:  Klin Wochenschr       Date:  1978-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.